insulinomas

GPTKB entity

Statements (57)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:associated_with gptkb:Company
ME N1 syndrome
gptkbp:can_lead_to long-term complications
quality of life issues
gptkbp:can_metastasize_to gptkb:theorem
liver
lymph nodes
gptkbp:caused_by seizures
headaches
hunger
hypoglycemia
loss of consciousness
gptkbp:counseling_services gptkb:theorem
gptkbp:descendant gptkb:theorem
gptkbp:first_described_by 1950s
gptkbp:has_style gptkb:theorem
https://www.w3.org/2000/01/rdf-schema#label insulinomas
gptkbp:is_associated_with insulin resistance
hyperinsulinemia
gptkbp:is_found_in pancreatic islets
beta cells
gptkbp:is_monitored_by symptom tracking
serum insulin levels
gptkbp:is_often_used_in adults
gptkbp:is_part_of syndromic conditions
gptkbp:is_studied_in genetic factors
treatment efficacy
pathophysiology
gptkbp:located_in pancreas
gptkbp:photography treatment planning
staging
gptkbp:produced_by gptkb:Company
gptkbp:rarity gptkb:Person
gptkbp:requires medical management
pancreatectomy
gptkbp:research clinical trials
gptkbp:scientific_classification multiple
solitary
functional
non-functional
gptkbp:social_responsibility gptkb:MRI
CT scan
blood tests
endoscopic ultrasound
72-hour fasting test
gptkbp:symptoms confusion
sweating
tremors
gptkbp:treatment gptkb:octreotide
gptkb:hospital
gptkb:theorem
gptkb:drug
high
diazoxide
gptkbp:bfsParent gptkb:multiple_endocrine_neoplasia_syndrome_type_2
gptkbp:bfsLayer 5